Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Mounjaro, manufactured by Eli Lilly, is a dual glucose-dependent insulinotropic peptide (GIP) and GLP-1 receptor agonist approved for managing type 2 diabetes mellitus and obesity
Your formulation may be customized by your provider during the consultation
Your specific dosing path depends on baseline health markers, body weight, metabolic rate, and how your GLP-1 receptors respond to the medication
It combines government SBIR funding with private matching capital, with awards averaging approximately $10 million
US$ 25.06
US$ 24.72
US$ 20.73
US$ 27.83
US$ 21.10
US$ 24.70
US$ 28.03
US$ 24.10
US$ 22.09
US$ 22.47
